STAB Chart
- 52-Week Range: $0.21 - $6.24
- Market Capitalization: $12.79M
- Short Percentage: 0%
- Target Price: $0.00
- Shares Outstanding: 50.02M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
STAB released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-Q FilingGlobeNewsWire | May 23rd
- Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K FilingGlobeNewsWire | April 22nd
- Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to EntolimodGlobeNewsWire | April 13th
- Statera Biopharma Announces Closing of $5.7 Million Underwritten Public OfferingGlobeNewsWire | March 24th
- CORRECTION -- Statera Biopharma Announces Proposed Underwritten Public OfferingGlobeNewsWire | March 22nd
Company Info
Website: https://www.staterabiopharma.com
Address: 2537 Research Boulevard, Fort Collins, CO, United States, 80526
Sector: Healthcare
Industry: Biotechnology
Full time employees: 18
Address: 2537 Research Boulevard, Fort Collins, CO, United States, 80526
Sector: Healthcare
Industry: Biotechnology
Full time employees: 18
$STAB buying this dip
$STAB breaking out of this wedge sooner than later
$STAB i am trading for a better future!
$STAB going green
$STAB ready to explode
$STAB must buyyy
$STAB Moon soon
$STAB very nice